Weekly TZP compared with prandial insulin, administered in addition to insulin glargine, proved reductions in HbA 1c and BW, not increased the risk of hypoglycemia (78, 79)
Keep a symptom diary noting bowel frequency, consistency (using the NHS Bristol Stool Chart as reference), associated symptoms, and dietary intake
If you have lost less than 5% of body weight after six months at maximum dose with good adherence, you may be a non-responder
All results were analyzed on an intention-to-treat basis that included the full analysis set (i.e., all patients who underwent randomization according to the planned treatment), with the exception of adverse events leading to premature discontinuation, which were included in the as-treated safety analysis
Talk to your doctor to find out if weight-loss medications are right for you
B-12 is a great addition to any Weight Loss program